These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 16041195

  • 1. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES, Madabushi R, Amry Sel-D, Bhattaram VA, Derendorf H.
    Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization.
    EL Desoky ES, Nagaraja NV, Derendorf H.
    Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E, Suematu F, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y, Aoyama T.
    Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062
    [Abstract] [Full Text] [Related]

  • 4. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW, Charland SL, Shaw LM, Kobrin S, Goldfarb S, Stanek EJ, Spinler SA.
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [Abstract] [Full Text] [Related]

  • 5. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
    Suematsu F, Yukawa E, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y.
    Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic accuracy of a hyperbolic model in predicting digoxin concentrations based on glomerular filtration rates.
    González-López J, Tutor JC.
    Nefrologia; 2011 Apr; 31(5):573-8. PubMed ID: 21959724
    [Abstract] [Full Text] [Related]

  • 7. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T.
    J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetic analysis of digoxin in Chinese neonates and infants.
    Gong Y, Chen Y, Li Q, Li Z.
    J Pharmacol Sci; 2014 Feb; 125(2):142-9. PubMed ID: 24837877
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics of levosimendan in patients with congestive heart failure.
    Jonsson EN, Antila S, McFadyen L, Lehtonen L, Karlsson MO.
    Br J Clin Pharmacol; 2003 Jun; 55(6):544-51. PubMed ID: 12814448
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetic investigation of digoxin in Japanese infants and young children.
    Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M.
    J Clin Pharmacol; 2011 Jun; 51(6):857-63. PubMed ID: 20592416
    [Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E, Akiyama K, Suematsu F, Yukawa M, Minemoto M.
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [Abstract] [Full Text] [Related]

  • 12. Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.
    Yukawa M, Yukawa E, Suematsu F, Takiguchi T, Ikeda H, Aki H, Mimemoto M.
    Drugs Aging; 2011 Oct 01; 28(10):831-41. PubMed ID: 21970310
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetic model of digoxin in older Chinese patients and its application in clinical practice.
    Zhou XD, Gao Y, Guan Z, Li ZD, Li J.
    Acta Pharmacol Sin; 2010 Jun 01; 31(6):753-8. PubMed ID: 20523346
    [Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetics of digoxin in pediatric patients.
    Martín-Suárez A, Falcao AC, Outeda M, Hernández FJ, González MC, Quero M, Arranz I, Lanao JM.
    Ther Drug Monit; 2002 Dec 01; 24(6):742-5. PubMed ID: 12451291
    [Abstract] [Full Text] [Related]

  • 15. Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin.
    Chicella M, Branim B, Lee KR, Phelps SJ.
    Ther Drug Monit; 1998 Jun 01; 20(3):347-51. PubMed ID: 9631935
    [Abstract] [Full Text] [Related]

  • 16. Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based on creatinine clearance.
    Konishi H, Shimizu S, Chiba M, Minouchi T, Koida M, Yamaji A.
    J Clin Pharm Ther; 2002 Aug 01; 27(4):257-65. PubMed ID: 12174027
    [Abstract] [Full Text] [Related]

  • 17. Efficiency of individual dosage of digoxin with calculated concentration.
    Zhao L, Yang P, Li P, Wang X, Qin W, Zhang X.
    Clin Interv Aging; 2014 Aug 01; 9():1205-10. PubMed ID: 25092970
    [Abstract] [Full Text] [Related]

  • 18. Population analysis for the optimization of digoxin treatment in Japanese paediatric patients.
    Suematsu F, Minemoto M, Yukawa E, Higuchi S.
    J Clin Pharm Ther; 1999 Jun 01; 24(3):203-8. PubMed ID: 10438180
    [Abstract] [Full Text] [Related]

  • 19. The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure.
    Carlton LD, Patterson JH, Mattson CN, Schmith VD.
    J Clin Pharmacol; 1996 Mar 01; 36(3):247-56. PubMed ID: 8690819
    [Abstract] [Full Text] [Related]

  • 20. Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach.
    ElDesoky ES, Kumar V, Alorainy MS, Hamdi MM, Derendorf H.
    Int J Clin Pharmacol Ther; 2008 Dec 01; 46(12):617-26. PubMed ID: 19049695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.